J&J Bolsters Key Portfolios with Dual FDA Nod and MedTech Launch
Johnson & Johnson gains FDA approval for a new frontline multiple myeloma therapy and unveils a pioneering cardiac imaging catheter, reinforcing its strategic focus on high-growth oncology and medical technology segments.